Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03278717
Title Study Evaluating the Efficacy of Maintenance Olaparib and Cediranib or Olaparib Alone in Ovarian Cancer Patients (ICON9)
Acronym ICON9
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors University College, London
Age Groups: adult | senior
Covered Countries NZL | GBR | CAN | AUS

No variant requirements are available.